Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Grant supports research on skin injuries caused by chemical threats, aiming to identify commonalities for medical countermeasure development.
Funder: National Institutes of Health
Due Dates: November 16, 2026 (Resubmission/revision) | February 16, 2027 (New) | March 16, 2027 (Resubmission/revision) | June 16, 2027 (New) | July 16, 2027 (Resubmission/revision) | October 16, 2027 (New) | November 16, 2027 (Resubmission/revision) | January 7, 2028 (Closing)
Funding Amounts: Up to $225,000 in direct costs annually and $450,000 total over up to 3 years
Summary: Supports planning-stage research on shared mechanisms of chemical skin injuries and therapeutic targets for medical countermeasures.
Key Information: Investigators must have no current or previous CCRP support, including CounterACT funding.
Description
This NIH R34 planning grant supports fundamental research on skin injuries caused by chemicals identified as high-consequence public health threats. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Institute of Allergy and Infectious Diseases (NIAID) run the initiative through the Chemical Countermeasures Research Program (CCRP). Its emphasis is on common mechanisms of injury, wound healing, and long-term consequences, including shared signaling pathways and therapeutic targets.
The initiative helps investigators new to CCRP-supported research establish a chemical countermeasure research direction. Projects may develop laboratory expertise, establish relationships with certified toxic-chemical facilities, and generate preliminary data for more comprehensive research. The ultimate goal is medical countermeasures effective against multiple Chemicals of Concern (CoCs), including vesicants and toxic industrial or corrosive chemicals.
